Patent · US Active

Automated cancer detection using MRI

US10215830B2 · kind B2 · utility

3Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 16, 2015
Grant dateFeb 26, 2019
Priority date
Expiry dateJan 2, 2037

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG06T2207/30081
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods and systems for diagnosing cancer in the prostate and other organs are disclosed. Exemplary methods comprises extracting texture information from MRI imaging data for a target organ, sometimes using two or more different imaging modalities. Texture features are determined that are indicative of cancer by identifying frequent texture patterns. A classification model is generated based on the determined texture features that are indicative of cancer, and diagnostic cancer prediction information for the target organ is then generated to help diagnose cancer in the organ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.